Where Are we with Vitamin E?

Area of Science:

• Cardiovascular Science
• Nutritional Science
• Medical Research

Background:

• Oxidative modification of low-density lipoproteins (LDL) is a key factor in atherogenesis.
• Naturally occurring antioxidants, like Vitamin E, are investigated for their potential to inhibit LDL oxidation and slow coronary artery disease (CAD) progression.
• Observational studies suggest a link between antioxidant vitamin intake and reduced cardiovascular mortality.

Purpose of the Study:

• To evaluate the role of Vitamin E in the primary and secondary prevention of coronary artery disease.
• To synthesize evidence from observational studies and clinical trials regarding Vitamin E's effect on atherosclerotic lesion formation and cardiovascular outcomes.

Main Methods:

• Review of observational epidemiologic data, including case-control and prospective cohort studies.
• Analysis of completed randomized interventional trials, including placebo-controlled studies.
• Consideration of ongoing large-scale randomized interventional trials.

Main Results:

• Animal models show Vitamin E reduces atherosclerotic lesion formation.
• Epidemiologic data suggest an association between Vitamin E intake and lower cardiovascular mortality.
• Evidence from clinical trials is conflicting, with some studies yielding inconclusive results.

Conclusions:

• Vitamin E shows promise as a protective agent against coronary artery disease.
• Conflicting data from clinical trials necessitate further investigation.
• Ongoing large randomized trials are expected to clarify Vitamin E's definitive role in CAD prevention.